期刊文献+

便秘型肠易激综合征60例临床观察 被引量:1

下载PDF
导出
摘要 目的探讨马来酸曲美布汀联合乳果糖治疗便秘型肠易激综合征(IBS)的疗效。方法随机将60例便秘型ISB分为治疗组和对照组,治疗组给予马来酸曲美布汀0.2口服每日3次,共4周,乳果糖7.5~15ml,口服每日1次,共4周。对照组给予马来酸曲美布汀0.2口服每日3次,共4周。结果两组间腹痛缓解情况在第1周末和第2周末的比较差异无显著性(P>0.05),而在第四周末两组比较差异有显著性(P<0.05),而粪便性状和排便频率在第1、2、4周末,两组比较差异有显著性(P<0.05)。结论马来酸曲美布汀联合乳果糖治疗便秘型IBS较单用马来酸曲美布汀疗效显著,不失为一种治疗便秘型IBS的良好选择。
作者 辛毅
机构地区 宿州市立医院
出处 《安徽医学》 2007年第6期519-520,共2页 Anhui Medical Journal
  • 相关文献

参考文献3

二级参考文献28

  • 1桂先勇 柯美云.肠易激综合征.现代胃肠病学[M].北京:科学出版社,1994.1293-1306.
  • 2MMPI全国协作组.中国人使用明尼苏达多相个性测查表的结果分析[J].心理学报,1985,17:346-354.
  • 3文碧珍 潘其英.健康人肠功能紊乱症状调查[J].中华流行病学杂志,1988,9(6):345-349.
  • 4Talley NJ, Zinsmeister AR, Van Dyke C, Melton LJ 3rd. Epidemiology of colonic symptoms and the irritable bowel syndrome. Gastroenterology, 1991,101: 927-934.
  • 5Jones R, Lydeard S. Irritable bowel syndrome in the general population. BMJ, 1992, 304: 87-90.
  • 6Drossman DA, Thompson WG, Talley NJ, FunchJensen P, Janssens J, Whitehead WE. Identification of sub-groups of functional bowel disorders.Gastroenterol Int, 1990, 3: 159-172.
  • 7Evans JM, Fleming KC, Talley NJ, Schleck CD,Zinsmeister AR, Melton LJ 3rd. Relation of colonic transit to functional bowel disease in older people: a population-based study. J Am Geriatr Soc,1998,46:83-87.
  • 8Wackerbauer R, Schmidt T, Widmer R, Pfeiffer A,Morrill G, Kaess H. Discrimination of irritable bowel syndrome by non-linear analysis of 24-h jejunal motility. Neurogastroenterol Motil, 1998, 10:331-337.
  • 9Small PK, Loudon MA, Hau CM, Noor N, Campbell FC. Large-scale ambulatory study of postprandial jejunal motility in irritable bowel syndrome. Scand J Gastroenterol, 1997, 32: 39-47.
  • 10Evans PR, Bak YT, Kellow JE. Effects of oral cisapride on small bowel motility in irritable bowel syndrome. Aliment Pharmacol Ther, 1997, 11:837 -844.

共引文献523

同被引文献17

  • 1梁荣新,郑琴芳,梁列新,张法灿.肠易激综合征与胃肠激素的关系[J].中国综合临床,2004,20(8):702-703. 被引量:32
  • 2钟英强,黄花荣,李楚强,苏红.活动期溃疡性结肠炎患者结肠黏膜中生长抑素受体的表达及其临床意义[J].新医学,2007,38(4):220-222. 被引量:6
  • 3钟英强,许哲,张世能,郭佳念,曾志勇.联用文拉法辛与匹维溴胺治疗伴抑郁状态的腹泻型肠易激综合征的对照研究[J].中国神经精神疾病杂志,2007,33(7):435-437. 被引量:17
  • 4Kellow JE, Azpiroz F, Delvaux M, et al. Applied principles of neurogastroenterology: physiology/motility sensation. Gastroenterology, 2006, 130 (5): 1412-1420.
  • 5Schwetz I, Naliboff B, Munakata J, et al. Antihyperalgesic effect of oetreotide in patients with irritable bowel syndrome. Aliment Pharmacol Ther, 2004, 19 (1): 123-131.
  • 6Drossman DA. The functional gastrointestinal disorders and the Rome III process. Gastroenterology, 2006, 130 (5): 1377-1390.
  • 7Fromowitz FB, Viola MV, Chao S, et al. ras p21 expression in the progression of breast cancer. Hum Pathol, 1987, 18 (12): 1268-1275.
  • 8Hope N, Butt G, Ross I, et al. Somatostatin enhances cAMP-dependent short-circuit current in human colon via somatostatin receptor subtype-2. Dig Dis Sci, 2001, 46 (11): 2499-2503.
  • 9Taniyama Y, Suzuki T, Mikami Y, et al. Systemic distribution of somatostatin receptor subtypes in human: an immunohistochemieal study. Endocr J, 2005, 52 (5): 605-611.
  • 10Corleto VD, Romano G, Severi C, et al. Human circular colonic smooth muscle cells possess active somatostatin receptors. Ital J Gastroenterol Hepatol, 1998, 30 (5): 505- 509.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部